Medistim ASA (LON:0OCD)
233.00
+8.00 (3.56%)
At close: Oct 20, 2025
Medistim ASA Revenue
Medistim ASA had revenue of 169.08M NOK in the quarter ending June 30, 2025, with 16.67% growth. This brings the company's revenue in the last twelve months to 628.08M, up 17.80% year-over-year. In the year 2024, Medistim ASA had annual revenue of 556.16M with 6.73% growth.
Revenue (ttm)
628.08M NOK
Revenue Growth
+17.80%
P/S Ratio
7.22
Revenue / Employee
4.08M NOK
Employees
154
Market Cap
327.35M GBP
Revenue Chart
* This company reports financials in NOK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 556.16M | 35.05M | 6.73% |
| Dec 31, 2023 | 521.11M | 34.85M | 7.17% |
| Dec 31, 2022 | 486.26M | 68.45M | 16.38% |
| Dec 31, 2021 | 417.82M | 61.61M | 17.30% |
| Dec 31, 2020 | 356.21M | -707.00K | -0.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Medistim ASA News
- 8 months ago - Medistim ASA (STU:MD1) Q4 2024 Earnings Call Highlights: Record Sales and Strategic Innovations ... - GuruFocus
- 8 months ago - Q4 2024 Medistim ASA Earnings Call Transcript - GuruFocus